Peter Vilmann

9.4k total citations · 2 hit papers
165 papers, 5.9k citations indexed

About

Peter Vilmann is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Peter Vilmann has authored 165 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Surgery, 80 papers in Pulmonary and Respiratory Medicine and 68 papers in Oncology. Recurrent topics in Peter Vilmann's work include Pancreatic and Hepatic Oncology Research (53 papers), Gastric Cancer Management and Outcomes (25 papers) and Pancreatitis Pathology and Treatment (23 papers). Peter Vilmann is often cited by papers focused on Pancreatic and Hepatic Oncology Research (53 papers), Gastric Cancer Management and Outcomes (25 papers) and Pancreatitis Pathology and Treatment (23 papers). Peter Vilmann collaborates with scholars based in Denmark, Italy and Germany. Peter Vilmann's co-authors include Marc Giovannini, Felix Herth, Mark Krasnik, Armin Ernst, Paul Frost Clementsen, Jean‐Marc Dumonceau, Robert T. Eberhardt, Lars Konge, Cesare Hassan and Adrian Săftoiu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Peter Vilmann

159 papers receiving 5.7k citations

Hit Papers

Endosonography-guided fin... 1997 2026 2006 2016 1997 2006 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Vilmann 2.9k 2.9k 2.2k 665 594 165 5.9k
Michael L. Kochman 4.9k 1.7× 3.2k 1.1× 3.5k 1.6× 1.3k 2.0× 712 1.2× 255 7.3k
Shabana F. Pasha 2.9k 1.0× 1.5k 0.5× 1.2k 0.5× 1.4k 2.0× 404 0.7× 106 4.1k
Ram Chuttani 3.8k 1.3× 2.6k 0.9× 1.5k 0.7× 905 1.4× 315 0.5× 134 4.7k
David E. Fleischer 7.7k 2.7× 4.5k 1.5× 1.6k 0.7× 4.5k 6.7× 431 0.7× 284 10.1k
Steven A. Edmundowicz 5.3k 1.8× 2.8k 1.0× 2.6k 1.2× 1.7k 2.5× 446 0.8× 216 6.9k
Celia M. Divino 3.4k 1.2× 1.4k 0.5× 2.0k 0.9× 442 0.7× 890 1.5× 221 7.9k
Nabil P. Rizk 3.8k 1.3× 5.1k 1.8× 1.2k 0.5× 283 0.4× 266 0.4× 164 6.9k
Hiran C. Fernando 3.4k 1.2× 4.9k 1.7× 701 0.3× 817 1.2× 140 0.2× 159 6.9k
Udaya B. S. Prakash 1.6k 0.6× 3.9k 1.3× 404 0.2× 177 0.3× 905 1.5× 169 5.7k
Stephen C. Yang 1.7k 0.6× 2.2k 0.8× 1.5k 0.7× 144 0.2× 480 0.8× 119 4.4k

Countries citing papers authored by Peter Vilmann

Since Specialization
Citations

This map shows the geographic impact of Peter Vilmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vilmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vilmann more than expected).

Fields of papers citing papers by Peter Vilmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Vilmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vilmann. The network helps show where Peter Vilmann may publish in the future.

Co-authorship network of co-authors of Peter Vilmann

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Vilmann. A scholar is included among the top collaborators of Peter Vilmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Vilmann. Peter Vilmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kovacevic, Bojan, et al.. (2025). EUS-Guided Radiofrequency Ablation as a Minimally Invasive Treatment for Insulinomas—A Single-Center Experience. The Journal of Clinical Endocrinology & Metabolism. 111(4). 988–992.
2.
Steenholdt, Casper, et al.. (2025). Scoping review: Patient-controlled sedation. Journal of Patient Safety and Risk Management. 31(1). 18–29.
3.
Vilmann, Peter, et al.. (2024). The clinical role of remimazolam: Protocol for a scoping review. Acta Anaesthesiologica Scandinavica. 68(7). 956–959. 2 indexed citations
4.
Kovacevic, Bojan, Peter Vilmann, Linea Cecilie Melchior, et al.. (2023). Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. Cancers. 15(14). 3677–3677. 6 indexed citations
5.
Kovacevic, Bojan, Anders Toxværd, Pia Klausen, et al.. (2023). Tissue amount and diagnostic yield of a novel franseen EUS-FNB and a standard EUS-FNA needle—A randomized controlled study in solid pancreatic lesions. Endoscopic Ultrasound. 12(3). 319–325. 13 indexed citations
6.
Moretti, Antonio, Bojan Kovacevic, Peter Vilmann, Jouke T. Annema, & Daniël A. Korevaar. (2023). Performance of EUS-FNA and EUS-B-FNA for the diagnosis of left adrenal glands metastases in patients with lung cancer: A systematic review and meta-analysis. Lung Cancer. 186. 107391–107391. 5 indexed citations
7.
Berthelsen, Ragna, Thomas Rades, Peter Vilmann, et al.. (2022). Physico-chemical characterization of aspirated and simulated human gastric fluids to study their influence on the intrinsic dissolution rate of cinnarizine. International Journal of Pharmaceutics. 622. 121856–121856. 10 indexed citations
8.
Shabanzadeh, Daniel Mønsted, Caroline Ewertsen, Hans Friis-Andersen, et al.. (2022). National clinical practice guidelines for the treatment of symptomatic gallstone disease: 2021 recommendations from the Danish Surgical Society. Scandinavian Journal of Surgery. 111(3). 11–30. 4 indexed citations
9.
Nielsen, Ole Haagen, Søren Jacobsen, Lene Riis, et al.. (2021). 1685P COLAR: Results from an intervention study investigating IL-6 blockade with tocilizumab for treatment of immune checkpoint inhibitor induced colitis and arthritis. Annals of Oncology. 32. S1180–S1180. 1 indexed citations
10.
Karstensen, John Gásdal, et al.. (2016). Biodegradable stents for the treatment of bowel strictures in Crohn's disease: technical results and challenges. SHILAP Revista de lepidopterología. 4(3). E296–E300. 30 indexed citations
12.
Møller, Ann Merete, et al.. (2015). Moderate and deep nurse-administered propofol sedation is safe.. PubMed. 62(4). A5049–A5049. 11 indexed citations
13.
Konge, Lars, et al.. (2015). High efficacy with deep nurse-administered propofol sedation for advanced gastroenterologic endoscopic procedures. SHILAP Revista de lepidopterología. 4(1). E107–E111. 17 indexed citations
14.
Hendel, Jakob, John Gásdal Karstensen, & Peter Vilmann. (2014). Serial intralesional injections of infliximab in small bowel Crohn's strictures are feasible and might lower inflammation. United European Gastroenterology Journal. 2(5). 406–412. 36 indexed citations
16.
Donatsky, Anders Meller, et al.. (2013). No increased risk of perforation during colonoscopy in patients undergoing Nurse Administered Propofol Sedation. Scandinavian Journal of Gastroenterology. 48(11). 1333–1338. 10 indexed citations
17.
Konge, Lars, Jouke T. Annema, Peter Vilmann, Paul Frost Clementsen, & Charlotte Ringsted. (2013). Transesophageal Ultrasonography for Lung Cancer Staging: Learning Curves of Pulmonologists. Journal of Thoracic Oncology. 8(11). 1402–1408. 30 indexed citations
19.
Herth, Felix, Ralf Eberhardt, Peter Vilmann, Armin Ernst, & Mark Krasnik. (2005). EBUS GUIDED BIOPSY FOR THE DIAGNOSIS OF MEDIASTINAL LYMPH NODES IN A RADIOLOGICALLY NORMAL MEDIASTINUM. CHEST Journal. 128(4). 211S–211S. 2 indexed citations
20.
Mortensen, Michael Bau, G. Caletti, Jacques Devière, et al.. (1996). Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.) Endoscopic Ultrasonography. Part II: Retroperitoneum and large bowel, Training.. Endoscopy. 28. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026